Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial. (Q49886860)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial. (English)

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

carbapenem antibiotic

0 references

1 reference

based on heuristic

inferred from title

11

object named as

Oren Zusman

0 references

Pia Clara Pafundi

object named as

Pia Clara Pafundi

13

0 references

Leonard Leibovici

27

object named as

Leonard Leibovici

1 reference

Europe PubMed Central

23 February 2018

1

object named as

Mical Paul

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

4

object named as

Dafna Yahav

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

Noa Eliakim-Raz

9

object named as

Noa Eliakim-Raz

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

Yaakov Dickstein

15

object named as

Yaakov Dickstein

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

George L Daikos

2

object named as

George L Daikos

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

7

object named as

Anna Skiada

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

Anastasia Antoniadou

12

object named as

Anastasia Antoniadou

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

5

object named as

Yehuda Carmeli

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

10

object named as

Amir Nutman

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

22

object named as

Inbar Levi

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

14

object named as

Amos Adler

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

Emanuele Durante-Mangoni

3

object named as

Emanuele Durante-Mangoni

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

8

object named as

Roberto Andini

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

25

object named as

Johan W Mouton

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

Ursula Theuretzbacher

26

object named as

Ursula Theuretzbacher

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

24

object named as

Lena E Friberg

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

21

object named as

Fidi Koppel

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

Yael Dishon Benattar

6

object named as

Yael Dishon Benattar

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

20

object named as

Hiba Zayyad

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

18

object named as

Vered Daitch

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

23

object named as

Tanya Babich

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

19

object named as

Roni Bitterman

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

author name string

Ioannis Pavleas

16

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

Rosa Zampino

17

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

publication date

15 February 2018

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

Lancet Infectious Diseases

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenems

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy for carbapenem-resistant Gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infection diseases specialists practicing in large hospitals.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors associated with carriage of carbapenem-non-susceptible Enterobacteriaceaein North-Eastern France and outcomes of infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness and safety of colistin: prospective comparative cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pitfalls of defining combination therapy for carbapenem-resistant Enterobacteriaceae in observational studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The Combined Use of Tigecycline with High-Dose Colistin Might Not be Associated With Higher Survival in Critically ill Patients With Bacteraemia Due to Carbapenem-Resistant Acinetobacter Baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy in severe Acinetobacter baumannii infections: an update on the evidence to date

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic and pharmacodynamic properties of meropenem

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Predominance of international clone 2 OXA-23-producing-Acinetobacter baumannii clinical isolates in Greece, 2015: results of a nationwide study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemic diffusion of OXA-23-producing Acinetobacter baumannii isolates in Italy: results of the first cross-sectional countrywide survey

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Informed consent, comparative effectiveness, and learning health care

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Closing the evidence gap in infectious disease: point-of-care randomization and informed consent

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930099-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1473-3099(18)30099-9

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

release_5mkaxovq2bembm4l44pjqgecdi

1 reference

https://api.fatcat.wiki/v0/release/5mkaxovq2bembm4l44pjqgecdi

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

23 February 2018

http://europepmc.org/abstract/MED/29456043

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49886860&oldid=1844215338"